| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.09 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.1 |